Anne Lockwood
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Anne Lockwood
Chief Financial and Commercial Officer / Integral Diagnostics
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 544th | PEXA Group | 8% | |
| 624th | Argo Investments | 3% | 7% |
| 976th | Integral Diagnostics | -17% | -0% |
| 1604th | helloworld | -59% | 3% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 230th |  | Integral Diagnostics | $440.8m |
| 276th | | Argo Investments | $303.3m |
| 277th | | Infigen Energy | $296.1m |
| 279th | | PEXA Group | $291.8m |
| 281st | | helloworld | $280.9m |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
 | NEW ROLE: Chief Financial and Commercial Officer, Integral Diagnostics | 24 Nov 2020 |
